Odyssey Therapeutics raises $279 million in IPO
Biotechnology firm Odyssey raises $279 million in its stock market debut.
Published 9sem1 sourceNotableupdated 9sem
Lire en français
≈ 17s
The fact
This fundraising marks a new wave of biotech sector investments in the United States.
Proceeds will fund innovative therapy development and clinical trial expansion.
Click the link to read an article on the topic: